Today’s AI Top Pick: TMDX

7/7/2026 · Swing Setup + Squeeze screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Swing Setup + SqueezeTMDXBUY NOW8.6 / 107/7/2026

TMDX is the cleanest confluence in the pool: it clears the fundamental screen with the strongest quality profile (PE 16.35, fwdPE 21.69, ROE 45.22%, profit margin 27.04%, salesYoY 30.24%, epsNextY +70.83%, analyst upside +63.2%, recom 1.64) AND has full multi-timeframe bullish confirmation with bullish_prob 1.0 and near_term_bullish 1.0. Fundamental score of 6.75 is second only to BKV's 8.0 — but unlike BKV, TMDX's tape is confirming. The forecast stack is aligned up across every horizon: 1h fc_short +1.79% / mid +5.7% / long +82.42%; 4h fc_mid +65.75% / long +124.16%; 1d fc_short +41.16% / mid +66% / long +55.3%; even the 1wk swings to +28.57% mid and +26.5% long after a brutal -46.94% 21-bar move. Critically, this is NOT a chase — the weekly position_in_21bar_range_pct is just 9.79% (deeply oversold), the daily is 38.88% (middle), and the 4h is 44.66%. Drawdown from 21-bar highs is -50.96% on the weekly, meaning we're buying capitulation, not FOMO. Only the 1h is elevated (85.46%) — a minor near-term extension, not a red flag. News flow is supportive without being euphoric: Stocktwits flagged a 77% analyst upside call on 7/1, Motley Fool named it a 'growth stock to buy on the dip' on 7/2, and there are no legal/regulatory/dilution landmines. Contrast this with MNDY (100% pos-in-range on 1h/4h — chase risk, and 1h forecasts negative), TARS (short-seller Culper Research alleging illegal copay scheme, hard pass), BKV (explicit dilution-fears SeekingAlpha piece and negative daily forecasts), and CIFR/SEI (weekly forecasts collapse -67% to -94%). TODAY is the entry because we have a rare combination: an oversold weekly (bottom decile of range, -51% DD) plus positive-turn forecasts across all four timeframes plus best-in-class profitability plus analyst tailwind plus a clean news slate. Waiting risks losing the low; the 1h is the only slightly stretched frame and can be managed with a staggered entry.

Entry zone

$69.50–$71.50 (scale in; add on any dip to $68 given 1h is extended)

Stop loss

$64.00 (below the 4h/1d recent structure; ~10% risk from mid-entry)

First target

$82–$85 (aligns with 4h/1d mid-horizon forecast of +5–10% and reclaim of prior consolidation)

Longer target

$105–$115 (1wk mid/long forecast of +26–28%, matches analyst upside 63% target zone ~$116)

Risks

Weekly recent_21bar_pct of -46.94% signals a broken longer-term trend — bounces off deep DD can fail; if $64 breaks, next support is materially lower
Short float 23.02% cuts both ways: squeeze fuel on good news, accelerant on bad news
Debt/Equity 1.75 is elevated for a growth-stage medtech — sensitive to any capital raise chatter
1h pos_in_21bar_range 85.46% means near-term is slightly stretched; a same-day pullback to $68–69 is plausible before continuation
Sector-specific: organ-transplant logistics (OCS) faces reimbursement and utilization risk; any negative operator/hospital commentary could reset the narrative

Honorable mentions

AVAVStrongest recom (1.26), massive salesYoY 140.89%, fresh $80.5M Titan MS defense contract on 7/7, bullish_prob 0.8, 1d fc_short +20.7% / mid +35.18%. Held back by negative margins (-13.41%), fwdPE 38.86, and 1wk fc_short of -18.83% suggesting choppy path.

VNETNear_term_bullish 1.0, deeply oversold (1wk pos 6.53%, DD -33.13%), fc_mid positive across all TFs, huge analyst upside 111%. Docked because fundamental_score is -0.25 (D/E 7.03, profitMargin -22.14%) and the recent governance/settlement headline is a real overhang.

Full ranking (12)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.6	Full multi-TF bullish alignment with best-in-class profitability and deeply oversold weekly — buy the capitulation.
2	AVAV	BUY NOW	6.8	Fresh $80.5M defense order and bullish 1d/4h forecasts, but margins/valuation cap conviction.
3	VNET	BUY PULLBACK	6.0	Oversold with near-term_bullish 1.0 and +111% analyst upside, but weak fundamentals and settlement overhang.
4	MNDY	BUY PULLBACK	5.6	Strong Q1 beat and daily/weekly forecasts explosive, but 1h/4h at 100% of range and 1h fc negative — wait for a dip to $76–78.
5	BKV	WAIT	4.8	Best fundamental_score (8.0) with CCS start-up catalyst, but bullish_prob 0 and daily forecasts turn negative — dilution fears in the news.
6	ARQT	WAIT	4.0	ZORYVE label expansion is a real positive, but weekly/daily forecasts sharply negative (-25% to -66% long).
7	SUPN	WAIT	3.8	Passes screen but bullish_prob 0 and all daily/weekly forecasts negative; no clear catalyst.
8	SAIL	WAIT	3.6	Guidance backed and Entro acquisition closed, but at 100% of 1h/4h range with negative near-term forecasts.
9	RGEN	WAIT	3.2	Evercore raised PT to $160 but PE 155/PS 10.45 stretched and daily forecasts negative -5% to -12%.
10	TARS	AVOID	2.5	Culper Research short report alleging illegal copay scheme — landmine trumps the bounce.
11	SEI	AVOID	2.2	Weekly forecasts collapse -37% to -77%; despite Wolfe initiation, tape is broken.
12	CIFR	AVOID	1.5	Profit margin -427%, gross margin -70.8%, and daily/weekly forecasts down -50% to -94% — broken setup.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord